Anchorage Capital Group, L.L.C. Ginkgo Bioworks Holdings, Inc. Transaction History

Anchorage Capital Group, L.L.C.

  • $361 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.63 - $3.52 $1.13 Million - $2.45 Million
696,239 Added 1.01%
69,854,593 $118 Million
Q4 2021

Feb 14, 2022
BUY
$8.31 - $14.92 $16.7 Million - $29.9 Million
2,006,986 Added 2.99%
69,158,354 $575 Million
Q3 2021

Nov 15, 2021
BUY
$9.15 - $13.28 $614 Million - $892 Million
67,151,368 New
67,151,368 $778 Million

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Anchorage Capital Group, L.L.C. Portfolio

Follow Anchorage Capital Group, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchorage Capital Group, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Anchorage Capital Group, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email